73 related articles for article (PubMed ID: 6446382)
1. Cefoperazone sodium: proceedings of the first international symposium, Boston, October, 1979.
Clin Ther; 1980; 3(Spec Issue):1-208. PubMed ID: 6446382
[No Abstract] [Full Text] [Related]
2. In vitro and in vivo microbiological evaluations of cefoperazone.
Renzini G; Ravagnan G; Piccolomini R; Dainelli B; Comanducci A
Clin Ther; 1980; 3(Spec Issue):139-44. PubMed ID: 6446388
[No Abstract] [Full Text] [Related]
3. Microbiological evaluation of cefoperazone, a new semisynthetic cephalosporin.
Blandino G; Dubini F; Russo G; Cocuzza G
Clin Ther; 1980; 3(Spec Issue):103-11. PubMed ID: 6446383
[No Abstract] [Full Text] [Related]
4. In vitro and in vivo antibacterial activity of cefoperazone.
Mitsuhashi S; Minami S; Matsubara N; Yotsuji A; Kurashige S; Saikawa I
Clin Ther; 1980; 3(Spec Issue):1-13. PubMed ID: 6446381
[No Abstract] [Full Text] [Related]
5. Cefoperazone: evaluation of the in vitro activity and an analysis of the disk diffusion test.
Thornsberry C; Baker CN; Barry AL; Jones RN
Clin Ther; 1980; 3(Spec Issue):39-45. PubMed ID: 6446397
[No Abstract] [Full Text] [Related]
6. Microbiological studies on cefoperazone.
Kayser FH
Clin Ther; 1980; 3(Spec Issue):24-33. PubMed ID: 6446395
[No Abstract] [Full Text] [Related]
7. A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibiotics.
Wise R; Gillett AP; Andrews JM
Clin Ther; 1980; 3(Spec Issue):149-55. PubMed ID: 6446391
[No Abstract] [Full Text] [Related]
8. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
Auckenthaler R; Waldvogel FA
Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
[No Abstract] [Full Text] [Related]
10. Comparative activity of cefoperazone against selected cephalosporinase-producing enteric bacteria.
Chabbert YA; Collatz E
Clin Ther; 1980; 3(Spec Issue):98-102. PubMed ID: 6446402
[No Abstract] [Full Text] [Related]
11. In-vitro antibacterial activity of cefoperazone, a piperazine cephalosporin.
King A; Warren C; Shannon K; Phillips I
J Antimicrob Chemother; 1981 Aug; 8(2):107-13. PubMed ID: 6456255
[No Abstract] [Full Text] [Related]
12. Regression analyses for cefoperazone on Mueller-Hinton agar and DST agar.
Langmaack H; Daschner F
Clin Ther; 1980; 3(Spec Issue):123-6. PubMed ID: 6446384
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of cefoperazone against clinical isolates of Enterobacteriaceae, Pseudomonas and Staphylococcus.
Olarte J
Clin Ther; 1980; 3(Spec Issue):130-3. PubMed ID: 6446386
[No Abstract] [Full Text] [Related]
14. [Cefoperazone--activity in vitro].
Hejzlar M; Silarová J; Pellar T; Kittnar E; Hájková L; Janatová E; Stastná L; Kotasová M; Puchmayerová M
Cesk Epidemiol Mikrobiol Imunol; 1983 Mar; 32(2):82-6. PubMed ID: 6220824
[No Abstract] [Full Text] [Related]
15. Inhibitory concentrations of cefoperazone, cefazolin, cefamandole, cephaloridine, and cefoxitin for 300 gram-negative clinical isolates.
Trabulsi LR; Pereira da Silva Almada N; Marques LR
Clin Ther; 1980; 3(Spec Issue):145-8. PubMed ID: 6446390
[No Abstract] [Full Text] [Related]
16. High resistance to fourth-generation cephalosporins among clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases isolated in Portugal.
Fernandes R; Gestoso A; Freitas JM; Santos P; Prudêncio C
Int J Antimicrob Agents; 2009 Feb; 33(2):184-5. PubMed ID: 18926667
[No Abstract] [Full Text] [Related]
17. Evolution of acquired resistance to third-generation cephalosporins in Enterobacteriaceae in a Tunisian hospital 1993-2001.
Boutiba-Ben Boubaker I; Ghozzi R; Ben Abdallah H; Mamlouk K; Kamoun A; Ben Redjeb S
Clin Microbiol Infect; 2004 Jul; 10(7):665-7. PubMed ID: 15214883
[TBL] [Abstract][Full Text] [Related]
18. Living with ESBLs. Introduction.
Cornaglia G; Garau J; Livermore DM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():1-2. PubMed ID: 18154523
[No Abstract] [Full Text] [Related]
19. In vitro activity of fourth generation cephalosporins against enterobacteriaceae producing extended-spectrum beta-lactamases.
Sanders CC
J Chemother; 1996 Feb; 8 Suppl 2():57-62. PubMed ID: 8738847
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
